CRL.US Charles River Laboratories

Healthcare Life Sciences Tools & Services USA Stocks
337.97 USD
Close of Nov 14, 2026
146.20 379.63
Market cap
USD 16.2B
P/E
367.4x
P/B
5.06x
ROE
13.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is CRL.US undervalued?

Graham number

The Graham number of Charles River Laboratories cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Charles River Laboratories fundamental analysis

No fundamental analysis for Charles River Laboratories yet.

Charles River Laboratories stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Charles River Laboratories

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical dru…

Full company profile